Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT

被引:47
|
作者
Rotta, Inajara [1 ]
Salgado, Teresa M. [2 ]
Felix, Daniel C. [3 ]
Souza, Thais T. [1 ]
Correr, Cassyano J. [4 ]
Fernandez-Llimos, Fernando [5 ]
机构
[1] Univ Fed Parana, Postgrad Program Pharmaceut Sci, BR-80060000 Curitiba, Parana, Brazil
[2] Univ Michigan, Coll Pharm, Dept Clin Social & Adm Sci, Ann Arbor, MI 48109 USA
[3] Univ Wisconsin Hosp & Clin, Dept Pharm, Madison, WI 53792 USA
[4] Univ Fed Parana, Dept Pharm, BR-80060000 Curitiba, Parana, Brazil
[5] Univ Lisbon, Res Inst Med iMed ULisboa, Dept Social Pharm, Fac Pharm, P-1649003 Lisbon, Portugal
关键词
evidence-based practice; outcome and process assessment (health care); pharmaceutical services; pharmacists; reproducibility of results; validation studies; CHRONIC KIDNEY-DISEASE; SYSTEMATIC REVIEWS; INTERVENTIONS; CARE; MANAGEMENT; ADHERENCE; QUALITY; IMPACT;
D O I
10.1111/jep.12339
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Rationale, aims and objectivesDEPICT (Descriptive Elements of Pharmacist Intervention Characterization Tool) was created in response to the frequently reported issue of poor intervention description across studies assessing the impact of clinical pharmacy activities. The aim of this study was to create an improved version of DEPICT (i.e. DEPICT 2) to better characterize clinical pharmacy services in order to ensure consistent reporting, therefore enhancing reproducibility of interventions in practice. MethodA qualitative approach through a thematic content analysis was performed to identify components of pharmacist interventions described in 269 randomized controlled trials. A preliminary version of DEPICT 2 was applied independently by two authors to a random sample of 85 of the 269 RCTs and reliability determined by the prevalence-adjusted bias-adjusted kappa (PABAK) or the intraclass correlation coefficient (ICC). The final version of DEPICT 2 was compared against DEPICT 1. ResultsThe final version of DEPICT 2 comprised 146 items and 11 domains. The inter-rater agreement analysis showed that DEPICT presented good to optimal reproducibility, with a mean PABAK value of 0.87 (95% CI 0.85-0.89) and a mean ICC value of 0.88 (95% CI 0.62-1.14). The mean difference between items checked in the two versions (DEPICT 2 - DEPICT 1) was 10.58 (95% CI 9.55-11.61), meaning that approximately 11 more components were identified in the new version of DEPICT. ConclusionsDEPICT 2 is a reliable tool to characterize components of clinical pharmacy services, which should be used to ensure consistent reporting of interventions to allow their reproducibility in practice.
引用
收藏
页码:584 / 590
页数:7
相关论文
共 11 条
  • [11] AHA/ACC/HHS Strategies to Enhance Application of Clinical Practice Guidelines in Patients With Cardiovascular Disease and Comorbid Conditions From the American Heart Association, American College of Cardiology, and US Department of Health and Human Services
    Arnett, Donna K.
    Goodman, Richard A.
    Halperin, Jonathan L.
    Anderson, Jeffrey L.
    Parekh, Anand K.
    Zoghbi, William A.
    CIRCULATION, 2014, 130 (18) : 1662 - +